ADMA Biologics ADMA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: ADMA Biologics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about ADMA Biologics's operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is ADMA Biologics's operating income?
- ADMA Biologics (ADMA) reported operating income of $58.27M in Q1 2026.
- How has ADMA Biologics's operating income changed year-over-year?
- ADMA Biologics's operating income increased by 67.1% year-over-year, from $34.88M to $58.27M.
- What is the long-term trend for ADMA Biologics's operating income?
- Over 4 years (2021 to 2025), ADMA Biologics's operating income has grown at a 34.6% compound annual growth rate (CAGR), from -$58.37M to $191.44M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.